🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to perform prospective data analysis on tumor ...
Status
Unknown
Location
UZ Brussel Radiotherapie dienst
Start Date
2013-01
Trial ID
NCT02224547
Treatments Being Tested
This is a phase I, multicenter, open-label study starting with a dose explo...
Status
Active Not Recruiting
Location
Institut Bergonié
Start Date
2023-12-12
Trial ID
NCT05821231
Treatments Being Tested
This phase II trial studies how well stereotactic body radiation therapy or...
Status
Suspended
Location
M D Anderson Cancer Center
Start Date
2017-05-22
Trial ID
NCT03164460
Treatments Being Tested
Lung cancer is the leading cause of cancer death worldwide with a crude inc...
Status
Unknown
Location
Cliniques Universitaires Saint-Luc
Start Date
2015-08
Trial ID
NCT01795521
Treatments Being Tested
For this study, unfavorable intermediate risk prostate cancer patients will...
Status
Recruiting
Location
NYU Langone Health
Start Date
2024-04-16
Trial ID
NCT06397703
Treatments Being Tested
This is a prospective, open-label, multi-center seamless phase II to phase ...
Status
Recruiting
Location
VA Long Beach Healthcare System, Long Beach, CA
Start Date
2021-07-01
Trial ID
NCT04787744
Treatments Being Tested
This is a randomized Phase II study which is designed to determine the impa...
Status
Terminated
Location
University of Texas Southwestern Medical Center
Start Date
2021-07-27
Trial ID
NCT04786093
Treatments Being Tested
RATIONALE: Extracranial stereotactic radiosurgery may be able to send x-ray...
Status
Completed
Location
Wake Forest University Comprehensive Cancer Center
Start Date
2002-06
Trial ID
NCT00311597
Treatments Being Tested
SBRT delivers high-dose radiation to precisely defined target volumes and i...
Status
Recruiting
Location
University Hospital Zurich
Start Date
2026-06-16
Trial ID
NCT07687147
Treatments Being Tested
Phase II clinical trial of PD-L1 in combination with vinorelbine + cyclopho...
Status
Recruiting
Location
Cancer Hospital, Chinese Academy of Medical Sciences
Start Date
2024-09-10
Trial ID
NCT06771609